Successful thrombolytic therapy for acute kidney injury secondary to thrombosis of suprarenal inferior vena cava filter

Kitchens, Craig S.

doi:10.1007/s11239-009-0359-6

Cited by 10 publications

(4 citation statements)

References 28 publications

(51 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although an IVC filter was originally intended to be placed inferior to the renal veins, it is sometimes placed in the suprarenal IVC when the proximal extent of the thrombus exceeds the renal vein. However, considering the risk of migration, fracture, and renal failure, a consensus for suprarenal IVC filter has not been fully established [ 3 , 4 , 15 ].…”

Section: Discussionmentioning

confidence: 99%

Percutaneous Thrombectomy with a Half-Deployed Stent for the Treatment of Acute Inferior Vena Cava Thrombosis

Jung

2020

VSI

View full text Add to dashboard Cite

Inferior vena cava (IVC) thrombosis, a type of deep vein thrombosis (DVT), is a relatively rare and poorly known disease compared to lower extremity DVT. We present a case of a 68-year-old woman with abdominal pain and mild lower leg swelling due to IVC thrombosis extending from the common iliac vein to the infrahepatic IVC. The thrombus was removed using a 14-mm Niti-S stent (Taewoong Medical, Korea) inserted via the right internal jugular vein. The stent was partially deployed and gently advanced to cover the thrombus, and then retracted through a vascular sheath capturing the thrombus. This case presents a therapeutic approach for the treatment of IVC thrombosis using a half-deployed stent as a filter and a basket. Follow-up evaluation after 5 years revealed a patent IVC and common iliac vein.

show abstract

Section: Discussionmentioning

confidence: 99%

Percutaneous Thrombectomy with a Half-Deployed Stent for the Treatment of Acute Inferior Vena Cava Thrombosis

Jung

2020

VSI

View full text Add to dashboard Cite

show abstract

“…The therapeutic methods for symptomatic IVC thrombosis following filter implantation include anticoagulant therapy, systemic thrombolysis, catheter-directed thrombolysis, mechanical thrombectomy, balloon dilation, stent placement and filter retrieval (5,7,23–31). …”

Section: Discussionmentioning

confidence: 99%

“…Thrombolytic therapy is of value in acute thrombosis. Bihorac and Kitchens reported that systemic thrombolytic therapy successfully treated acute kidney injury secondary to thrombosis of a suprarenal IVC filter (23). Infusion of tissue plasminogen activator (tPA) through a thrombolytic catheter has successfully treated a patient with bilateral renal vein thrombosis due to IVC filter migration and thrombosis (7).…”

Section: Discussionmentioning

confidence: 99%

Transcatheter thrombolytic therapy for symptomatic thrombo-occlusion of inferior vena cava filter

Xiao

Shen

Tong

et al. 2012

Experimental and Therapeutic Medicine

View full text Add to dashboard Cite

Thrombus within an inferior vena cava (IVC) filter reduces filter patency and venous return from the lower extremities, and may progress to complete IVC occlusion. The clinical experiences and outcomes of transcatheter thrombolytic therapy for symptomatic IVC thrombosis following filter implantation have not been widely reported. The aim of the current study was to evaluate the efficiency and safety of trans-catheter thrombolysis for the treatment of symptomatic IVC thrombosis in patients with implanted IVC filters. Transcatheter thrombolysis was used to treat 5 patients with thrombosis of the filter-bearing IVC causing symptoms in 10 limbs from October 2005 to September 2010. The patients were implanted with a second IVC filter through the right internal jugular vein, followed by recanalization of the occluded IVC and intravenous transcatheter thrombolysis. The IVC filters were retrieved through the femoral or right internal jugular vein after the thrombus had dissolved. Technical and clinical outcome, complications and postoperative pulmonary embolism were monitored. A total of 5 filters were implanted and 6 filters were retrieved later. Technically and clinically successful recanalization and thrombolysis were achieved in 5 of 5 patients and 10 of 10 symptomatic limbs. The median thrombolysis period was 13 days (range, 8–14 days). The median dwell time for the filters that were removed was 50.5 days (range, 14–73 days). No major bleeding occurred during the current study. During clinical follow-up, no clinically detectable pulmonary embolism was observed. Endovascular recanalization and transcatheter thrombolysis of IVC thrombosis are efficient, feasible and safe in the presence of an IVC filter.

show abstract

“…Deployment of the filter in the suprarenal position is advocated in certain clinical conditions, and some reports suggest a higher incidence of renal complications in that position, especially among patients with malignancy. Therefore, it was ascertained that Suprarenal IVCF placement should be performed rarely, and then, only after careful evaluation of the underlying renal function, and most likely it should be avoided in patients with malignancy and known hypercoagulable state [10,11] .…”

Section: Introductionmentioning

confidence: 99%

Inferior Vena Cava Filters: Two Years Experience in King Abdulaziz University Hospital

Jabbad

Arabia²

2010

med

View full text Add to dashboard Cite

Pulmonary embolism remains a serious challenge for health care. Anticoagulation is considered the first line of treatment; however, in patients with anticoagulation failure or contraindication, inferior vena cava filter placement has been widely performed for the prevention of pulmonary embolism. This study is a retrospective review of King Abdulaziz University Hospital two years experience (2008-2009). Nineteen patients who had venous thromboembolic manifestations were subjected to inferior vena cava filter insertion. The main reasons for inferior vena cava filter insertion were the occurrence of venous thromboembolism on top of anticoagulants, and bleeding resulted from heparin induced thrombocytopenia. All of the patients were presented with one or more risk factors and co-morbidities among malignancies were the most common (52.6%). Insertion was successful for all cases, except one patient who had pre-existing massive inferior vena cava thrombosis. No complications were recorded during filter insertion or on the short term, after filter insertion. Medical indications for inferior vena cava filters in our hospital are not different from what was cited in the literature. Although, each individual patient had multiple risk factors and co-morbidities, nevertheless our patients had no complications related to inferior vena cava filter insertion, which denotes that inferior vena cava filters can be inserted properly and safely.

show abstract

Successful thrombolytic therapy for acute kidney injury secondary to thrombosis of suprarenal inferior vena cava filter

Cited by 10 publications

References 28 publications

Percutaneous Thrombectomy with a Half-Deployed Stent for the Treatment of Acute Inferior Vena Cava Thrombosis

Percutaneous Thrombectomy with a Half-Deployed Stent for the Treatment of Acute Inferior Vena Cava Thrombosis

Transcatheter thrombolytic therapy for symptomatic thrombo-occlusion of inferior vena cava filter

Inferior Vena Cava Filters: Two Years Experience in King Abdulaziz University Hospital

Contact Info

Product

Resources

About